Akebia Therapeutics (AKBA) Reports Q3 Net Loss of $59.5M, Cash and Cash Equivalents of $207.2M
Go back to Akebia Therapeutics (AKBA) Reports Q3 Net Loss of $59.5M, Cash and Cash Equivalents of $207.2M| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 1.10 +0.01 (0.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $13.20 | |||
| Open | $1.09 | 52 Week Low | $7.00 | |||
| Day High | $1.14 | P/E | N/A | |||
| Day Low | $1.09 | EPS | $0.00 | |||
| Volume | 2,437,812 | |||||
